Point72 Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $31.2M | Sell |
|
|||||
|
2020
Q3 | $156M | Buy |
|
|||||
|
2020
Q2 | $136M | Buy |
|
|||||
|
2020
Q1 | $57.7M | Buy |
|
|||||
|
2019
Q4 | $36.6M | Sell |
|
|||||
|
2019
Q3 | $41.1M | Buy |
|
|||||
|
2019
Q2 | $5.75M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $75M | Buy |
|
|||||
|
2018
Q3 | $101M | Buy |
|
|||||
|
2018
Q2 | $54.4M | Buy |
|
|||||
|
2018
Q1 | $9.47M | Sell |
|
|||||
|
2017
Q4 | $26.6M | Buy |
|
|||||
|
2017
Q3 | $8.4M | Sell |
|
|||||
|
2017
Q2 | $51.4M | Buy |
|
|||||
|
2017
Q1 | $19.4M | Sell |
|
|||||
|
2016
Q4 | $48.7M | Sell |
|
|||||
|
2016
Q3 | $74.9M | Buy |
|
|||||
|
2016
Q2 | $61.8M | Buy |
|
|||||
|
2016
Q1 | $11.9M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $1.83M | Buy |
|